News for 'National Pharmaceutical Pricing Policy'

NDA more eager to cap drug prices than UPA

NDA more eager to cap drug prices than UPA

Rediff.com14 Jan 2016

The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Rediff.com13 Sep 2022

Anti-infectives like Ivermectin, Mupirocin and Meropenem have also been added to the list, taking the total drugs under it to 384.

US Firms Back Trump's India Tariffs

US Firms Back Trump's India Tariffs

Rediff.com31 Mar 2025

Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald Trump dispensation to push India to reduce tariffs, non-tariffs, and regulatory barriers to boost American exports.

Anti-cancer drugs to be cheaper soon

Anti-cancer drugs to be cheaper soon

Rediff.com18 Jun 2013

The drug pricing regulator on Tuesday said it will fix the ceiling prices of over 300 medicines by the end of this month, a move that will come as a major relief to patients.

509 essential drugs to be costlier

509 essential drugs to be costlier

Rediff.com8 Apr 2015

The government regulates prices of all other medicines.

Trump 2.0: Tough Navigation Lies Ahead For India

Trump 2.0: Tough Navigation Lies Ahead For India

Rediff.com12 Feb 2025

'As the global economy undergoes significant transformations in 2025, India's ability to navigate the complexities of trade wars, financial realignments, and emerging blocs will be pivotal,' explain Harsh V Pant and Soumya Bhowmik.

Drug regulator lets pharma firms fix own penalty

Drug regulator lets pharma firms fix own penalty

Rediff.com20 Jan 2014

Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.

Consumers may have to pay more for insulin

Consumers may have to pay more for insulin

Rediff.com21 Mar 2014

Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Rediff.com12 Mar 2025

Apple's ambitious strategy to expand iPhone exports, shift more production from China to India at a faster pace, and grow its domestic market hits a Trump-sized roadblock.

Excise on drugs reduced to 8%

Excise on drugs reduced to 8%

Rediff.com29 Dec 2005

How drug firms dodge government rules

How drug firms dodge government rules

Rediff.com5 Aug 2013

A probe finds several pharma majors in breach of the law; and in turn they blame the government.

Big decisions of Modi govt in the last 6 months

Big decisions of Modi govt in the last 6 months

Rediff.com25 Nov 2014

A look at the key decisions taken by the Narendra Modi government in its six months.

Bulk drug prices may be freed

Bulk drug prices may be freed

Rediff.com16 Jan 2006

Markets consolidate; Sensex defends 25k

Markets consolidate; Sensex defends 25k

Rediff.com14 Jul 2014

Infosys, Wipro and HUL among the top losers for the day.

Major General S C N Jatar: An Unsung Hero

Major General S C N Jatar: An Unsung Hero

Rediff.com25 Oct 2023

Major General S C N Jatar, who passed into the ages on Monday night, thwarted anti-national forces at the peak of the Assam agitation. Colonel Anil A Athale (retd) salutes this officer and gentleman.

Ram Teri Ganga Maili

Ram Teri Ganga Maili

Rediff.com12 Jun 2024

Six decades and more later, we are now captives of our identities. Every poll is based on elaborate calculations of electability of candidates on the basis of their castes and other narrow definers. That, along with voter promiscuity, is what defines our political culture, which remains stubbornly resistant to any change, asserts Shreekant Sambrani.

Repackaged drugs likely to be labelled 'new'

Repackaged drugs likely to be labelled 'new'

Rediff.com2 Jan 2014

Roadblocks ahead as these medicines could face new clinical tests, more scrutiny

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

FDI policy in pharma set for major overhaul

FDI policy in pharma set for major overhaul

Rediff.com16 Aug 2013

After a high-level meeting held on Friday chaired by Prime Minister Manmohan Singh, it has been decided that the Commerce and Industry would soon start a consultation process to address 'dangers inherent' in the current model of FDI in brownfield pharma units.

Exports dip 10.3% in May; trade deficit at 5-month high

Exports dip 10.3% in May; trade deficit at 5-month high

Rediff.com15 Jun 2023

Exports declined for the fourth-consecutive month by 10.3 per cent year-on-year to $34.98 billion in May, while the trade deficit widened to a five-month high of $22.12 billion. According to the data released by the commerce ministry on Thursday, key export sectors recording negative growth include petroleum products, gems and jewellery, engineering goods, ready-made garments of all textiles and chemicals. Imports also declined 6.6 per cent, six-month in a row, to $57.1 billion against $61.13 billion in the same month last year, the data showed.

'There is clearly a 17 - 18% upside in the markets over the next 12-15 months'

'There is clearly a 17 - 18% upside in the markets over the next 12-15 months'

Rediff.com5 Apr 2023

Earnings growth, attractive valuations and change in FPI flows from negative to positive over the next 12 months are some of the key triggers for an upside. "A poor monsoon, high inflation and further rate hike are some of the key risks

Pharma in 2014: Deals worth billions and fines worth millions

Pharma in 2014: Deals worth billions and fines worth millions

Rediff.com26 Dec 2014

In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.

Strong US growth to boost pharm cos' fortune in FY14

Strong US growth to boost pharm cos' fortune in FY14

Rediff.com12 Jun 2013

Revival in domestic business should also help overall revenue growth.

'Fed rate cut appears unlikely'

'Fed rate cut appears unlikely'

Rediff.com17 Mar 2023

'The Fed rate will peak in the range of 5.1-5.3 per cent during the second quarter of CY23 and will most likely stay there for a while before rate cuts start in CY24.'

'We are exploring setting up an aerotropolis'

'We are exploring setting up an aerotropolis'

Rediff.com10 Mar 2023

'We would like to develop Andhra Pradesh into a logistics hub not only for India, but also for South Asia.'

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Rediff.com25 Feb 2022

There is no direct impact of the Russia-Ukraine crisis on India in terms of bilateral trade but a surge in oil prices poses considerable risk to the economy, an analyst report said on Friday. International oil prices which have surged past $100 per barrel "pose risks to external stability and currency movement," a Bank of Baroda Economics Research report said. Russia has launched military operations against Ukraine, stoking fears of significant disruption in the region, including loss of life. The West is ramping up financial sanctions against Russia and support for Ukraine.

Ayushman Bharat may help patients access life-saving drugs

Ayushman Bharat may help patients access life-saving drugs

Rediff.com16 May 2018

'We have often heard the mythical argument that patents block access to life-saving drugs, but only 5% of medicines from multinational companies are under patent protection in India.' 'Where these patented products are beyond the reach of Indian patients, the companies have programmes to facilitate access to their drugs, for free or for a fraction of the price,' points out Ranjana Smetacek, former director general, Organisation of Pharmaceutical Producers of India.

All about a duel on drugs

All about a duel on drugs

Rediff.com13 Feb 2014

The South African government and large pharmaceutical companies are in combat mode regarding the proposed national policy on intellectual property that hopes to improve access to medicines for the poorer sections of the population.

'Maligning the medical fraternity was not expected of PM'

'Maligning the medical fraternity was not expected of PM'

Rediff.com22 Apr 2018

The Indian Medical Association and the Mumbai Association of Medical Consultant have written a letter to Narendra Modi expressing disappointment over his statement during the Bharat ki Baat Sabke saath event in London.

We are safe only when everyone is safe

We are safe only when everyone is safe

Rediff.com7 Jul 2021

So vaccinate employees and families, staff at home, rickshaw drivers, milkmen, service providers, shopkeepers and street vendors, says Naushad Forbes.

'In the short-term, the markets will remain volatile'

'In the short-term, the markets will remain volatile'

Rediff.com28 Aug 2020

'There is still scope for selective stockpicking.'

Why replacing branded drugs with generics won't be easy

Why replacing branded drugs with generics won't be easy

Rediff.com25 May 2017

Mandatory prescription of generic names is not a complete solution. Rather, in the absence of a range of approaches, it could mean passing the choice of selecting a drug from a doctor to a pharmacist, says Chandrakant Lahariya.

One month of lockdown: Small-caps outperform Sensex, mid-caps

One month of lockdown: Small-caps outperform Sensex, mid-caps

Rediff.com24 Apr 2020

The S&P BSE Small-cap index has recovered 26 per cent as compared to a 23 per cent rise in the S&P BSE Sensex.

Modi's Self-Created Perfect Storm

Modi's Self-Created Perfect Storm

Rediff.com20 May 2021

Triumphalism, premature declaration of victory meant no one checked if India had enough vaccines, oxygen, remdesivir, bringing us back to a crisis where we need foreign aid after four decades, asserts Shekhar Gupta.

'After Covid, demand will be back with a vengeance'

'After Covid, demand will be back with a vengeance'

Rediff.com11 Dec 2020

'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'

Markets wobble on Chinese woes, Fed hike fears

Markets wobble on Chinese woes, Fed hike fears

Rediff.com20 Aug 2015

The FMCG index gained more than 1% on the back of stellar gains in ITC.

'FDI policy should be seen in light of Make in India'

'FDI policy should be seen in light of Make in India'

Rediff.com15 Jul 2016

With EU, it is part of the FTA that we will need to negotiate.

Corporate spying: CBI arrests commerce ministry employee

Corporate spying: CBI arrests commerce ministry employee

Rediff.com16 Mar 2015

CBI has also summoned a senior official of Reliance Industries Limited and a noted chartered accountant.